Squamous cell carcinoma grouphad significantly correlated Ki 67 levels with overall survival (OS), and p53 levels had significantly correlated with progression free survival (PFS) andOS.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background: There have been some relationship between Ki-67 and P53 expression and the standardized uptake value (SUVmax) of the primary lesion duringpositron emission tomography-computed tomography (PET-CT) in lung cancers.Methods: The staining density of Ki-67 and p53 expression in 31 cases were diagnosed with non-small cell carcinoma (NSLCL) and 13 cases were diagnosed withsmall cell carcinoma (SCLC) have been investigated..Results: Ki-67 % was significantly correlated with SUVmax values in patients with lung cancer in all subtypes (adenocarcinoma, squamous and small celllung cancer) but the regression analysis was more prominent in adenocarcinoma and squamous cell carcinoma.
📊
Key Findings & Data:Squamous cell carcinoma grouphad significantly correlated Ki 67 levels with overall survival (OS), and p53 levels had significantly correlated with progression free survival (PFS) andOS.
💡
Conclusion & Impact:Squamous cell lung carcinoma subtype is highly expressedp53 and Ki 67 with might predicted by SUVmax and these findings are significantly correlated with oncologic outcomes. .Keywords: Ki 67, p53, SUV max, Lung cancer
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Background: There have been some relationship between Ki-67 and P53 expression and the standardized uptake value (SUVmax) of the primary lesion duringpositron emission tomography-computed tomography (PET-CT) in lung cancers.Methods: The staining density of Ki-67 and p53 expression in 31 cases were diagnosed with non-small cell carcinoma (NSLCL) and 13 cases were diagnosed withsmall cell carcinoma (SCLC) have been investigated..Results: Ki-67 % was significantly correlated with SUVmax values in patients with lung cancer in all subtypes (adenocarcinoma, squamous and small celllung cancer) but the regression analysis was more prominent in adenocarcinoma and squamous cell carcinoma. Squamous cell carcinoma grouphad significantly correlated Ki 67 levels with overall survival (OS), and p53 levels had significantly correlated with progression free survival (PFS) andOS. Adenocarcinoma and small cell lung carcinoma patients did not have any significant correlation between the Ki 67, p53 and OS as well as PFS.Conclusions: There is a strong correlation between the SUVmax and pathologic staining of Ki 67 and p53. Squamous cell lung carcinoma subtype is highly expressedp53 and Ki 67 with might predicted by SUVmax and these findings are significantly correlated with oncologic outcomes. .Keywords: Ki 67, p53, SUV max, Lung cancer
🔖
Cite This Article
Bedir, R., Yusufoğlu, B., Bilir, C., Güngör, S., Şehitoğlu, İ., Yurdakul, C., Asa, S., Morcalı, H. (2016). Relationship Between The 18F-FDG Uptake with Ki-67 and P53 Expression in Patients with Lung Cancer: A Clino-Pathologic Study. Journal of Human Rhythm, Cilt: 2 - Sayı: 3, 1–1. https://ajindex.com/articles/835852
Bilir C, Balık MS, Kızılkaya B, Yıldırım S, Gemez S, Bilir F. Serum LactateDehydrogenase Levels May Predict Fentanyl Usage in Patients withMetastatic Cancers for The Treatment of Cancer Related Pain. J hum rhythm. 2016;2(2):78-82. de Geus-Oei L, van Krieken JH, Aliredjo R, Krabbe PF, Frielink C, VerhagenAF, Boerman OC, Oyen WJ. Biological correlates of FDG uptake in nonsmallcell lung cancer. Lung Cancer. 2007; 55: 79–87.
Kieninger A, Welsh R, Bendick P, Zelenock G, Chmielewski GW. Positronemissiontomography as a prognostic tool for early-stage lung cancer. AmJ Surg. 2006; 191:433-436. Vesselle H1, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, WoodDE. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucoseuptake by positron emission tomography. Clin Cancer Res. 2000;6:3837-3844. Higashi K1, Ito K, Hiramatsu Y, Ishikawa T, Sakuma T, Matsunari I, KugaG, Miura K, Higuchi T, Tonami H, Yamamoto I. 18F-FDG uptake by primarytumor as a predictor of intratumoral lymphatic vessel invasion and lymphnode involvement in non-small cell lung cancer: analysis of a multicenterstudy. J Nucl Med. 2005;46:267-273.
Zhang ZJ, Chen JH, Meng L, Du JJ, Zhang L, Liu Y, Dai HH. 18F-FDG uptakeas a biologic factor predicting outcome in patients with resected non-smallcelllung cancer. Chin Med J (Engl). 2007;120:125-131.
Jeong HJ, Min JJ, Park JM, Chung JK, Kim BT, Jeong JM, Lee DS, Lee MC, Han SK, Shim YS. Determination of the prognostic value of [(18)F] fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. 2002;23:865-870.
Viberti L, Papotti, M, Abbona G.C, Celano,A, Filosso PL, Bussolati G. Valueof Ki-67 immunostaining in preoperative biopsiesof carcinomas of the lung.Hum. Pathol.1997;28:189-192.
Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer (Phila.). 1988;61:1776–1781.
Haberkorn U, Strauss LG, Reisser C, Haag D, Dimitrakopoulou A, ZiglerS, Oberdorfer F, Rudat V, VanKaick G. Glucose uptake, perfusion, andcell proliferation in head and neck tumors: relation of positron emission